Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Increased sodium and water excretion is a renal physiological response mediated by multiple molecular systems, primarily by decreasing the reabsorption of sodium and water along the nephron. It is clinically targeted by diuretics, which modulate the activity of channels and transporters such as NKCC2 in the thick ascending limb, NCC in the distal convoluted tubule, and the epithelial sodium channel (ENaC) in the collecting duct. This process helps regulate extracellular fluid volume, blood pressure, and correct volume overload states such as heart failure and edema. Because the term represents a process or outcome rather than a discrete molecular entity, it is not a valid canonical therapeutic target.
Inhibition of sodium reabsorption in different nephron segments; Blockade of transporters like Na-K-2Cl cotransporter (NKCC2), Na-Cl cotransporter (NCC); Antagonism of aldosterone or vasopressin signaling
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Increased sodium and water excretion.